Stock listing
NSRX Stock Price, News, Filings & Events — Nasus Pharma Ltd.
Selected listing: NSRX · AMEX · USD · US
This page tracks Nasus Pharma Ltd.'s NSRX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NSRX:AMEX. NSRX:AMEX is the stock-level entry point for investors researching Nasus Pharma Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nasus Pharma Ltd. is a public company traded under the ticker NSRX in the American market. The company has a market capitalization of approximately $25.2 million. Nasus Pharma focuses on developing innovative pharmaceutical solutions.
- Ticker
- NSRX:AMEX
- Asset type
- Stock
- Market cap
- $39.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AMEX
- Currency
- USD
Nasus Pharma Ltd. NSRX:AMEX stock context
This page tracks Nasus Pharma Ltd.'s NSRX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NSRX:AMEX. NSRX:AMEX is the stock-level entry point for investors researching Nasus Pharma Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nasus Pharma Ltd. is a public company traded under the ticker NSRX in the American market. The company has a market capitalization of approximately $25.2 million. Nasus Pharma focuses on developing innovative pharmaceutical solutions.
Latest news from Nasus Pharma Ltd.
Nasus Pharma Announces Transition of Chief Financial Officer
August 19, 2026
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
August 17, 2026
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
July 28, 2026
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
June 9, 2026
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
March 25, 2026
Research Nasus Pharma Ltd.
Nasus Pharma Ltd. investor report
Review AI stock analysis and investor report context for NSRX:AMEX.
Nasus Pharma Ltd. company profile
View the public company page for Nasus Pharma Ltd. on 6ix.
Nasus Pharma Ltd. news
Read company news and market updates connected to Nasus Pharma Ltd..
Nasus Pharma Ltd. investor events
Find investor webinars, events, and replay context for Nasus Pharma Ltd..